Only show
results from:

Sort results by:

Display preferences
131 results sorted by relevancy Results per page:
BioVex Submits IND for Clinical Trial of OncoVEX(GM-CSF) in Malignant Melanoma.
PR Newswire; May 4, 2005; 700+ Words OXFORD, England, May 4 /PRNewswire/ -- BioVex Ltd, a company developing new generation vaccines...OncoVEX(GM-CSF) is a significant milestone for BioVex" said Gareth Beynon, CEO of BioVex. "We believe the combination of oncolytic activity...
BioVex Submits IND for Clinical Trial of OncoVEXGM-CSF in Malignant Melanoma.
PR Newswire Europe; May 4, 2005; 700+ Words OXFORD, England, May 4 /PRNewswire/ -- BioVex Ltd, a company developing new generation vaccines...OncoVEXGM-CSF is a significant milestone for BioVex" said Gareth Beynon, CEO of BioVex. "We believe the combination of oncolytic activity...
BioVex's OncoVEX(GM-CSF) Clinical Trial Data to Be Featured by American Association for Cancer Research at 96th Annual Meeting; - OncoVEX Results Selected From 6,200 Abstract Submissions -.
PR Newswire; Apr 19, 2005; 700+ Words ...Calif., April 19 /PRNewswire/ -- BioVex Ltd, a leading developer of new generation...6,200 papers and abstracts and BioVex's presentation of its clinical...expected to begin later in 2005. BioVex's Chief Scientific Officer and...
BioVex's OncoVEX(GM-CSF) Clinical Trial Data to Be Featured by American Association for Cancer Research at 96th Annual Meeting.
PR Newswire Europe; Apr 19, 2005; 700+ Words ...From 6,200 Abstract Submissions BioVex Ltd, a leading developer of new generation...6,200 papers and abstracts and BioVex's presentation of its clinical...expected to begin later in 2005. BioVex's Chief Scientific Officer and...
BIOVEX COMPLETES #10 MILLION PRIVATE PLACEMENT.
PR Newswire; Jul 30, 2001; 700+ Words BioVex develops novel therapies for cancer and chronic infectious disease PR Newswire, London, July 30. This press release is transmitted on behalf of BioVex Ltd. BioVex Limited, a leading company developing treatments for cancer and chronic...
BIOVEX BEGINS PRE-CLINICAL DEVELOPMENT WITH OncoVEX FOR THE TREATMENT OF SOLID TUMOURS.
PR Newswire; Sep 27, 2000; 673 Words ...system disorders and infectious disease. BioVex's abstract at the Fifth Cold Spring Harbor...J.Smith (2), R.S. Coffin1 (2), BioVex Ltd. and University College London). 1 : BioVex Limited 2 : University College London This...
BioVex Announces Upcoming Presentation at American Association For Cancer Research 96th Annual Meeting.
PR Newswire; Apr 14, 2005; 700+ Words ...England, April 14 /PRNewsire/ -- BioVex Ltd, a leading developer of new generation...tmills@biovex.com, both of BioVex Ltd, +44(0)1235-441900; Jonathan...both of Financial Dynamics, for BioVex Ltd Web site: http://www.biovex...
BioVex Begins Phase I/II Clinical Trial of ImmunoVEXtrimelan with the Dosing of Malignant Melanoma Patient.
PR Newswire; Apr 27, 2005; 700+ Words ...England, April 27 /PRNewswire/ -- BioVex Ltd, a leading developer of new generation...is the first cancer vaccine from BioVex's ImmunoVEX platform to enter the...said Dr. Gareth Beynon, CEO of BioVex. "The initiation of the phase I...
BioVex Raises [pounds sterling]17M, Aims For Phase II OncoVEX Trial.
BIOWORLD Today; Oct 7, 2003; ; 700+ Words ...International Correspondent LONDON - BioVex Ltd. raised [pounds sterling]17 million...Dusseldorf, Germany. Going forward, BioVex is looking for merger and acquisition...Phase III." Abingdon,UK-based BioVex's OncoVEX is a modified herpes...
BIOVEX, LEADING GENE DELIVERY COMPANY, SIGNS AGREEMENT WITH U.S. BIOTECH COMPANY EPIMMUNE INC.
PR Newswire; Sep 5, 2000; 700+ Words ...September 5. This press release is transmitted on behalf of BioVex Ltd. BioVex Limited, one of the UK's leading gene delivery companies...applications including cancer and chronic infectious disease. BioVex will provide Epimmune with specific vectors from its...
BioVex Names Group Leader of Immunology.(Brief Article)
Cancer Weekly; Dec 4, 2001; 700+ Words ...com & NewsRx.net) -- BioVex, Ltd. has appointed Dr. Philip Reay...leader, immunology. Prior to joining BioVex, Reay was a senior research fellow...University of Oxford, England. "BioVex's key focus is on the development...
United States : BioVex Raises $30 Million.
TendersInfo; Nov 11, 2009; 700+ Words ...Science Partners will join the BioVex board of directors. Securing...significant milestone that puts BioVex in a strong financial position...Sparke, President and CEO of BioVex. We believe this over-subscribed...Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate.info...
Financing Roundup BioVex Raises $40M to Fund Melanoma Vaccine Study.
BIOWORLD Today; Mar 31, 2009; ; 700+ Words ...last round in November 2007, BioVex raised $35 million. The latest...existing investors following on. BioVex said that given the clinical...animal models of the disease. BioVex has permission for a Phase I...of common stock. Mesoblast Ltd., of Melbourne, Australia...
Sucampo, BioVex Line Up To Take Shot At Public Markets.
BIOWORLD Today; Jun 21, 2006; ; 700+ Words ...up to $86.25 million, and BioVex Inc., which hopes to raise...with Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, Amitiza...Cambridge, Mass.-based BioVex Inc., which is focused on...tumor deposits. In February, BioVex said the first patients in its...
BioVex Inc-Company Report.
M2 Presswire; Jan 24, 2009; 488 Words ...companiesandmarkets.com: BioVex Inc-Company Report(C)1994-2009 M2 COMMUNICATIONS LTD RDATE:24012009 -www.companiesandmarkets.com adds new report: BioVex Inc-Company Report Private...J9SMQW8G762594 ((M2 Communications Ltd disclaims all liability for...
AMERICAN SOCIETY OF GENE THERAPY BIOVEX, SCHERING, ETC. HIGHLIGHT GENE THERAPY STRIDES IN CANCER.
BIOWORLD Today; Jun 4, 2009; ; 700+ Words ...Another late-stage gene therapy player to present at ASGT was BioVex Inc., which presented updated Phase II melanoma data on OncoVEX...sensitivity to Rituxan (rituximab, F. Hoffmann-La Roche Ltd. and Biogen Idec Inc.). The researchers said the approach...
Adprotech Being Acquired By Inflazyme In C$20M Deal.(Inflazyme Pharmaceuticals Ltd)
BIOWORLD Today; Apr 13, 2004; ; 700+ Words ...shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9...000 per month. McBeath, who was CEO of BioVex Ltd., of Oxford, UK, before he joined Inflazyme...
PRIVATE EQUITY WEEK SCOREBOARD.
Private Equity Week; Aug 6, 2001; 700+ Words ...Sugar Land, TX Energy exploration BioVex Ltd. Oxford, UK Develops gene delivery...2001 1 $18M Energy exploration BioVex Ltd. 07/30/2001 2 $14.2M Develops...Energy IPerseus LLC Energy exploration BioVex Ltd. GeneChem Financial Corp.; Merlin...
Other News To Note.
BIOWORLD Today; Jun 11, 2002; 700+ Words ...terms were not disclosed. BioVex Ltd., of Oxford, UK, entered...evaluate the ability of BioVex's ImmunoVEX vaccine platform...chronic infectious disease, BioVex noted. Financial terms...disclosed. Cell Therapeutics Ltd., a wholly owned subsidiary...
PR Newswire National Summary, Monday, July 30, 2001 to 10 A.M. EDT.
PR Newswire; Jul 30, 2001; 700+ Words ...Automotive and Tokico Ltd. Sign Strategic Alliance...2001 01:00 r f bc-BioVex-10M-placement (LONDON) BioVex Completes 10 Million...Private Placement; BioVex Develops Novel Therapies...Formula Systems (1985) Ltd. to Spin Off Shares...
131 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives